Skip to content
Research Article Open access CC BY 4.0

Serological Evaluation of a Cohort of Patients with Chronic Chagas Disease Treated with Benznidazole in a Low Endemic Area of Central Brazil

Alinne R. Casé-Leite, Willian R. Camarço, Samuel N. M. Carvalho-Campos, Georges B. Hofmeister, Cor J. F. Fontes, Luciano T. Gomes

Journal of Advances in Medicine and Medical Research · pp. 348–358 · Published 2 Nov 2023

10.9734/jammr/2023/v35i225273

Abstract

Background: The most widely accepted criterion for assessing the cure of chronic Chagas disease after etiological therapy is the negativization of anti-Trypanosoma cruzi antibodies long after the completion of treatment. Materials and Methods: We employed various serological antibody detection techniques to ascertain whether benznidazole treatment successfully cured chronic Chagas disease in a retrospective cohort of patients in a low-endemic area in central Brazil. Antibodies were assessed using indirect immunofluorescence (IIF) and enzyme immunoassay (ELISA) before treatment and 1-18 years post-treatment. A reevaluation of 89 patients was conducted in 2018, which included indirect hemagglutination (IHA), chemiluminescence (CL), and polymerase chain reaction (PCR) analyses. Results: Seventeen patients were monitored for 15 years or more, seven for 10-15 years, 50 for 6-10 years, and 17 for 1-5 years. Only two patients who received treatment tested PCR-positive at reevaluation, indicating treatment failure. Both patients discontinued treatment early due to benznidazole's side effects. The incidence of serological test negativization was 10.1%. However, antibody levels determined by ELISA decreased with the increased duration of follow-up (p=0.002). Similarly, antibody titers of IIF-positive sera were lower in post-treatment reevaluations than those in pre-treatment titers, indicating reduced levels of anti-T. cruzi antibodies. These levels decreased in a duration-dependent manner during follow-up. Conclusion: The results reveal a low cure rate based on antibody negativization, but antibody titers significantly decreased in all conventional serological tests. These findings suggest that decreased antibody levels may be associated with parasitological cure in patients with chronic Chagas disease after etiological treatment with benznidazole. Further prospective studies should be conducted to confirm and validate these findings.

Chagas disease treatment benznidazole cure criterion conventional serology

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.